메뉴 건너뛰기




Volumn 29, Issue 1, 2002, Pages 36-40

Prognostic factors in mesothelioma

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIRUBICIN; ETOPOSIDE; MITOXANTRONE; PACLITAXEL;

EID: 0036179622     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.30299     Document Type: Article
Times cited : (39)

References (26)
  • 7
    • 0023146761 scopus 로고
    • Randomized comparison of cyclophosphamide, imidazole carboxamide, and Adriamycin versus cyclophosphamide and Adriamycin in patients with advanced stage malignant mesothelioma: A Sarcoma Intergroup study
    • (1987) J Clin Oncol , vol.5 , pp. 86-91
    • Samson, M.K.1    Wasser, L.P.2    Borden, E.C.3
  • 9
    • 0026707972 scopus 로고
    • Malignant mesothelioma: Prognostic factors in a prospective study of 9 patients
    • (1992) Lung Cancer , vol.8 , pp. 175-184
    • Tammilehto, L.1
  • 12
    • 0001444934 scopus 로고
    • Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retropsective study of 188 consecutive patients
    • (1993) Cancer , vol.72 , pp. 410-417
    • Ruffle, P.1    Feld, R.2    Minkin, S.3
  • 14
    • 0023840617 scopus 로고
    • Malignant mesothelioma: Prognostic variables in a registry of ISO patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985
    • (1988) J Clin Oncol , vol.6 , pp. 147-153
    • Antman, K.H.1    Shemin, R.2    Ryan, L.3
  • 19


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.